PY 8/28/24 PY 8/28/24 Advanced Techniques in pMDI Characterisation: Insights from Ab Initio and OzUK Read More PY 8/13/24 PY 8/13/24 Ab Initio Pharma Team Shines at Sydney City to Surf Event Read More PY 6/21/24 PY 6/21/24 Learn about Inhaled Biologics at SMI London Conference Read More PY 6/11/24 PY 6/11/24 Join us at ARCS 2024 Read More PY 5/29/24 PY 5/29/24 Unlock Innovation in Australia: Discover the Advantages of Partnering with Ab Initio Pharma Read More PY 5/23/24 PY 5/23/24 Learn About Ab Initio’s Turnkey solution for Inhalation Product development and cGMP Manufacture Read More PY 5/21/24 PY 5/21/24 Learn about Ab Initio’s Clinical Trial GMP Services Read More PY 5/15/24 PY 5/15/24 Join us at Bio 2024 Read More PY 5/13/24 PY 5/13/24 AB INITIO PHARMA PARTNERS WITH ENDO AXIOM TO MANUFACTURE INNOVATIVE NANOTECHNOLOGY-BASED ORAL INSULIN Read More PY 5/9/24 PY 5/9/24 Discover Ab Initio's CDMO Nasal Services - from R&D to finished GMP product manufacture Read More PY 5/6/24 PY 5/6/24 Streamlined MDI Development Partnership Read More PY 5/3/24 PY 5/3/24 Join us at RDD Read More PY 4/2/24 PY 4/2/24 DO YOU KNOW WHAT IS IN YOUR TRIAL MEDICINE? Read More PY 12/6/23 PY 12/6/23 Prof Daniela Traini gives prestigious Annual Lecture at Drug Delivery to the Lungs 2023 Read More PY 11/20/23 PY 11/20/23 Ab Initio opens new R&D Facility at Macquarie Park Read More PY 10/13/23 PY 10/13/23 Ab Initio signs Master Service Agreement with ResolutionRX Read More PY 9/16/23 PY 9/16/23 Tetratherix and Ab Initio Sign Landmark Deal to Commercialise Novel Drug Delivery Technology. Read More PY 8/30/23 PY 8/30/23 Ab Initio CSO receives ISAM award Read More PY 7/20/23 PY 7/20/23 Ab Initio CEO gives Keynote opening speech at the Annual Drug Discovery Initiative ECR Symposium Read More PY 7/17/23 PY 7/17/23 Ab Initio proud to Sponsor Sydney Innovation Week 2023 Read More Newer Posts Older Posts
PY 8/28/24 PY 8/28/24 Advanced Techniques in pMDI Characterisation: Insights from Ab Initio and OzUK Read More
PY 5/29/24 PY 5/29/24 Unlock Innovation in Australia: Discover the Advantages of Partnering with Ab Initio Pharma Read More
PY 5/23/24 PY 5/23/24 Learn About Ab Initio’s Turnkey solution for Inhalation Product development and cGMP Manufacture Read More
PY 5/13/24 PY 5/13/24 AB INITIO PHARMA PARTNERS WITH ENDO AXIOM TO MANUFACTURE INNOVATIVE NANOTECHNOLOGY-BASED ORAL INSULIN Read More
PY 5/9/24 PY 5/9/24 Discover Ab Initio's CDMO Nasal Services - from R&D to finished GMP product manufacture Read More
PY 12/6/23 PY 12/6/23 Prof Daniela Traini gives prestigious Annual Lecture at Drug Delivery to the Lungs 2023 Read More
PY 9/16/23 PY 9/16/23 Tetratherix and Ab Initio Sign Landmark Deal to Commercialise Novel Drug Delivery Technology. Read More
PY 7/20/23 PY 7/20/23 Ab Initio CEO gives Keynote opening speech at the Annual Drug Discovery Initiative ECR Symposium Read More
